Impact of Ursodeoxycholic Acid on Biliary Complications after Bariatric Surgery

Background: Biliary complications after Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) may occur due to rapid weight loss. Ursodeoxycholic acid (UCDA) has been shown to reduce the risk of biliary complications after bariatric surgery in a 1995 randomized controlled trial. The impact of UCDA in patients who have had SG is not well understood. Our objective was to review the incidence of biliary complications requiring intervention in patients after RYGB or SG and assess the timing of treatments based on whether UCDA was prescribed.

Source: Surgery for Obesity and Related Diseases - November 1, 2018 Category: Surgery Authors: Erin Caddell, Jacob Palubicki, Joel R Brockmeyer, Andrew J. Borgert, Kara J. Kallies, Byron J Faler, Yong Choi, Shanu N Kothari Source Type: research